CLINICAL_TRIALS
trial_result
· 2022-06-21
Clinical Trial Update: Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation [Phase 4]
Summary
Phase 4 trial update on very high power ablation in patients with atrial fibrillation undergoing first pulmonary vein isolation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AZ Sint-Jan AV | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED